Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 674.95

+3.1%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biotechwantabe who wrote (2958)	5/19/2020 6:39:17 PM
From: CuttingEdge Bio	of 3557

Well I dunno if they will test in marmosets, but that was considered the toughest model for infectious respiratory disease that researchers test MERS in. I think the more important lesson from this study is that a coronavirus primarily attacking the respiratory system and branching from there could create a quite different scenario than Ebola virus, and may make treatment with antibody approach much more challenging for wuhan virus. It is still true that this virus impacts far more than just the lungs, and so even if the lungs can't be efficiently targeted, clearing things up in the rest of the body could still greatly help fighting the infection. But you have to question how well this approach will work for a coronavirus attacking the lungs.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next